Success Metrics

Clinical Success Rate
94.1%

Based on 16 completed trials

Completion Rate
94%(16/17)
Active Trials
1(4%)
Results Posted
75%(12 trials)
Terminated
1(4%)

Phase Distribution

Ph phase_1
3
13%
Ph early_phase_1
1
4%
Ph not_applicable
5
22%
Ph phase_4
11
48%
Ph phase_2
3
13%

Phase Distribution

4

Early Stage

3

Mid Stage

11

Late Stage

Phase Distribution23 total trials
Early Phase 1First-in-human
1(4.3%)
Phase 1Safety & dosage
3(13.0%)
Phase 2Efficacy & side effects
3(13.0%)
Phase 4Post-market surveillance
11(47.8%)
N/ANon-phased studies
5(21.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

94.1%

16 of 17 finished

Non-Completion Rate

5.9%

1 ended early

Currently Active

1

trials recruiting

Total Trials

23

all time

Status Distribution
Active(2)
Completed(16)
Terminated(1)
Other(4)

Detailed Status

Completed16
unknown4
Active, not recruiting1
Terminated1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
23
Active
1
Success Rate
94.1%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (4.3%)
Phase 13 (13.0%)
Phase 23 (13.0%)
Phase 411 (47.8%)
N/A5 (21.7%)

Trials by Status

unknown417%
active_not_recruiting14%
terminated14%
completed1670%
not_yet_recruiting14%

Recent Activity

Clinical Trials (23)

Showing 20 of 23 trialsScroll for more
NCT03167905Phase 2

CODEPAD (Collaborative Outcomes of DEpression and Pain Associated With Delivery)

Active Not Recruiting
NCT07711522Early Phase 1

Quadro-Iliac Plane Block for Pain Control After Posterior Spinal Instrumentation Surgery

Not Yet Recruiting
NCT02858310Phase 1

E7 TCR T Cells for Human Papillomavirus-Associated Cancers

Completed
NCT05035407Phase 1

T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial Cancers

Terminated
NCT02867800Phase 1

Abatacept for GVHD Prophylaxis After Hematopoietic Stem Cell Transplantation for Pediatric Sickle Cell Disease

Completed
NCT04068948Phase 4

Comparing Pediatric Dental Oral Sedation Outcomes With and Without Meperidine in Children Aged 3-7 Years

Completed
NCT06082076Phase 2

Prevention of Shivering Associated With Spinal Anesthesia

Unknown
NCT04735965Phase 4

Comparison of Dexmedetomidine and Meperidine for the Prevention of Shivering Following Coronary Artery Bypass Graft

Unknown
NCT05110469Phase 4

Comparison of MgSO4 Versus Meperidine for Prevention of Shivering During Spinal Anesthesia

Completed
NCT01555671Phase 4

Study of the Effectiveness of Administration of Meperidine on the Length of Active Phase of Labor in Women

Completed
NCT04446715Not Applicable

Comparison of Meperidine and Sufentanil Added to 0.5% Hyperbaric Bupivacaine for Spinal Anesthesia in Cesarean Section

Unknown
NCT02486328Phase 4

The Effect of Different Sedation Regimes on Cognitive Function in Lower Gastrointestinal System Endoscopy

Completed
NCT02625181Not Applicable

Real-time Decision Support for Postoperative Nausea and Vomiting (PONV) Prophylaxis

Completed
NCT01741259Not Applicable

A Comparison of Meperidine for Post-Cesarean Analgesia: Bolus Versus Infusion and Bolus

Completed
NCT02684942Phase 4

Comparison of Meperidine and Fentanyl on Pain Scale and QOL in Brachytherapy

Completed
NCT01948921Not Applicable

Meperidine for Patients Expected to Have Poor Tolerance During Diagnostic Esophagogastroduodenoscopy.

Completed
NCT02027311Phase 4

Etomidate vs. Midazolam for Sedation During ERCP

Completed
NCT01693185Phase 4

Remifentanil Only vs. Midazolam and Meperidine During Elective Colonoscopy

Completed
NCT01709422Phase 4

Efficacy and Safety Profiles of Combination Sedation Propofol With Midazolam and Meperidine.

Completed
NCT01547520Not Applicable

Meperidine as the Single Sedative Agent During Esophagogastroduodenoscopy

Completed

Drug Details

Intervention Type
DRUG
Total Trials
23